New challenges arise as Medicare Prescription drug program continues to evolve.

As the new Medicare prescription drug program moves forward and other reforms are implemented, this new publication provides insight into the implications of this program and will also provide invaluable guidance on future developments.

(PRWEB) January 25, 2004 --Research and Markets announces the addition of the Medicare Drug Monitor to its offerings.

As the new Medicare prescription drug program moves forward and other reforms are implemented, this new publication provides insight into the implications of this program and will also provide invaluable guidance on future developments.

Also provided are clear and actionable advice on responding to evolving issues. For example, each issue of the Medicare Drug Monitor contains in-depth articles on critically important issues as well as special sections detailing newly issued regulations, coverage decisions, coding challenges, new products, and perspectives important to manufacturers, state Medicaid programs, dual eligible populations, and other public payer programs.

For a complete index of this report click on http://www.researchandmarkets.com/reports/42816

About Research and Markets Ltd.
Research and Markets Ltd. are Europe's largest resource for market research. R&M distribute thousands of major research publications from the world's leading publishers, consultants and market analysts. R&M provide you with the latest forecasts on international and regional markets, key industries, the top companies, new products and the latest market trends.

For additional information on ResearchandMarkets.com, their range of reports or their value-added services, visit their web site at http://www.researchandmarkets.com or mailto:press@researchandmarkets.com